Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets

Annals of the New York Academy of Sciences

Volumn 1266, Issue 1, 2012, Pages 94-106

  Sivasubramaniyan, Kavitha ^a   Lehnen, Daniela ^a   Ghazanfari, Roshanak ^a   Sobiesiak, Malgorzata ^a   Harichandan, Abhishek ^a   Mortha, Elisabeth ^a   Petkova, Neli ^a   Grimm, Sabrina ^a   Cerabona, Flavianna ^a   de Zwart, Peter ^b   Abele, Harald ^a   Aicher, Wilhelm K ^a   Faul, Christoph ^a   Kanz, Lothar ^a   Bühring, Hans Jörg ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bone marrow; Mesenchymal stem cells; MSC subsets; Placenta; Prospective isolation

Indexed keywords

ALPHA1 INTEGRIN; CD146 ANTIGEN; CD56 ANTIGEN; CD63 ANTIGEN; CELL SURFACE PROTEIN; ENDOGLIN; HEAT SHOCK PROTEIN 90; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN SH3; TNAP PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMNION; ARTICLE; BONE MARROW; CELL GROWTH; CELL HETEROGENEITY; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; HUMAN; MESENCHYMAL STEM CELL; PHENOTYPE; STEM CELL EXPANSION;

EID: 84865384024     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06551.x     Document Type: Article

References (92)

1. Friedenstein, A.J., U. Deriglasova & N. Kulagina 1974. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 2: 83-92.
2. Friedenstein, A.J., J. Gorskaja & N. Kulagina 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4: 267-274.
3. Battula, V.L., S. Treml, P.M. Bareiss, et al 2009. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94: 173-184.
4. Maijenburg, M.W., M. Kleijer, K. Vermeul, et al 2011. Primary bone marrow-derived MSC subsets have distinct Wnt-signatures compared to conventionally cultured MSC and differ in their capacity to support hematopoiesis in vitro. In Proceedings of the 53rd Annual Meeting of the American Society of Hematology, San Diego, CA
5. Maijenburg, M.W., M. Kleijer, K. Vermeul, et al 2012. The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging. Haematologica 97: 179-183.
6. Nauta, A.J. & W.E. Fibbe 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
7. Amado, L.C., A.P. Saliaris, K.H. Schuleri, et al 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102: 11474-11479.
8. Rojas, M., J. Xu, C.R. Woods, et al 2005. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Cell Mol. Biol. 33: 145-152.
9. Maitra, B., E. Szekely, K. Gjini, et al 2004. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33: 597-604.
10. Parr, A.M., C.H. Tator & A. Keating 2007. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 40: 609-619.
11. Soncini, M., E. Vertua, L. Gibelli, et al 2007. Isolation and characterization of mesenchymal cells from human fetal membranes. J. Tissue Eng. Regen. Med. 1: 296-305.
12. Schallmoser, K., C. Bartmann, E. Rohde, et al 2007. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
13. Pittenger, M.F., A.M. Mackay, S.C. Beck, et al 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
14. Battula, V.L., S. Treml, H. Abele & H.J. Buhring 2008. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76: 326-336.
15. Hu, Y., L. Liao, O. Wang, et al 2003. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J. Lab Clin. Med. 141: 342-349.
16. Jin, H.J., Y. Nam, Y. Bae, et al 2010. GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells. Cell Mol. Life Sci. 67: 1845-1858.
17. Lin, K., Y. Matsubara, Y. Masuda, et al 2008. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10: 417-426.
18. Lu, L., Y. Liu, S. Yang, et al 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
19. Martin, J., K. Helm, P. Ruegg, et al 2008. Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 10: 120-151.
20. Traktuev, D., S. Merfeld-Clauss, J. Li, et al 2008. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res. 102: 77-85.
21. Yoshimura, K., T. Shigeura, D. Matsumoto, et al 2006. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J. Cell Physiol. 208: 64-76.
22. Zannettino, A., S. Paton, A. Arthur, et al 2008. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J. Cell Physiol. 214: 413-421.
23. Zvaifler, N., L. Marinova-Mutafchieva, G. Adams, et al 2000. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2: 477-488.
24. Yen, B.L., H.I. Huang, C.C. Chien, et al 2005. Isolation of multipotent cells from human term placenta. Stem Cells 23: 3-9.
25. Sobiesiak, M., K. Sivasubramaniyan, C. Hermann, et al 2010. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 19: 669-677.
26. Buhring, H.J., S. Treml, F. Cerabona, et al 2009. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann. N. Y. Acad. Sci. 1176: 124-134.
27. Gronthos, S., S. Fitter, P. Diamond, et al 2007. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. 16: 953-963.
28. Bernardo, M.E., J.A. Emons, M. Karperien, et al 2007. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect. Tissue Res. 48: 132-140.
29. Battula, V.L., P.M. Bareiss, S. Treml, et al 2007. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75: 279-291.
30. Muller, I., S. Kordowich, C. Holzwarth, et al 2006. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 8: 437-444.
31. Bieback, K., A. Hecker, A. Kocaomer, et al 2009. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
32. Vogel, W., F. Grunebach, C.A. Messam, et al 2003. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 88: 126-133.
33. Fickert, S., J. Fiedler & R.E. Brenner 2003. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage 11: 790-800.
34. Varma, M., R. Breuls, T. Schouten, et al 2007. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev. 16: 91-104.
35. Quirici, N., C. Scavullo, L. de Girolamo, et al 2010. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem Cells Dev. 19: 915-925.
36. Mitchell, J., K. McIntosh, S. Zvonic, et al 2006. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24: 376-385.
37. Martins, A., A. Paiva, J. Morgado, et al 2009. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant. Proc. 41: 943-946.
38. Deschaseaux, F., F. Gindraux, R. Saadi, et al 2003. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br. J. Haematol. 122: 506-517.
39. Gindraux, F., Z. Selmani, L. Obert, et al 2007. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res. 327: 471-483.
40. Letchford, J., A. Cardwell, K. Stewart, et al 2006. Isolation of C15: a novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow. J. Immunol. Methods 308: 124-137.
41. Rider, D., T. Nalathamby, V. Nurcombe & S. Cool 2007. Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J. Mol. Histol. 38: 449-458.
42. Stewart, K., P. Monk, S. Walsh, et al 2003. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res. 313: 281-290.
43. Baksh, D., P. Zandstra & J. Davies 2007. A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells. Biotechnol. Bioeng. 98: 1195-1208.
44. Delorme, B., J. Ringe, N. Gallay, et al 2008. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111: 2631-2635.
45. Liu, P., D. Zhou & T. Shen 2005. Identification of human bone marrow mesenchymal stem cells: preparation and utilization of two monoclonal antibodies against SH2, SH3. Zhongguo Shi Yan. Xue. Ye. Xue. Za Zhi. 13: 656-659.
46. Odabas, S., F. Sayar, G. Guven, et al 2008. Separation of mesenchymal stem cells with magnetic nanosorbents carrying CD105 and CD73 antibodies in flow-through and batch systems. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 861: 74-80.
47. Campioni, D., F. Lanza, S. Moretti, et al 2008. Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy 10: 69-82.
48. Schwab, K., P. Hutchinson & C. Gargett 2008. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum. Reprod. 23: 934-943.
49. Arufe, M., A. De la Fuente, I. Fuentes-Boquete, et al. 2009. Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J. Cell Biochem. 108: 145-155.
50. Aslan, H., Y. Zilberman, L. Kandel, et al 2006. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24: 1728-1737.
51. Jarocha, D., E. Lukasiewicz & M. Majka 2008. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells. Folia Histochem. Cytobiol. 46: 307-314.
52. Kastrinaki, M.C., I. Andreakou, P. Charbord & H. Papadaki 2008. Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile. Tissue Eng. Part C. Methods 14: 333-339.
53. Alsalameh, S., R. Amin, T. Gemba & M. Lotz 2004. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 50: 1522-1532.
54. Tsuji, S., M. Yoshimoto, K. Takahashi, et al 2008. Side population cells contribute to the genesis of human endometrium. Fertil. Steril. 90: 1528-1537.
55. Conconi, M., P. Burra, R. Di Liddo, et al 2006. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int. J. Mol. Med. 18: 1089-1096.
56. Gronthos, S., A. Zannettino, S. Hay, et al 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 116: 1827-1835.
57. Gronthos, S. & A. Zannettino 2008. A method to isolate and purify human bone marrow stromal stem cells. Methods Mol. Biol. 449: 45-57.
58. De Coppi, P., G. Bartsch, Jr., M.M. Siddiqui, et al 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25: 100-106.
59. Schwab, K. & C. Gargett 2007. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum. Reprod. 22: 2903-2911.
60. Sorrentino, A., M. Ferracin, G. Castelli, et al 2008. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol. 36: 1035-1046.
61. Astori, G., F. Vignati, S. Bardelli, et al 2007. "In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J. Transl. Med. 5: 55.
62. Horn, P., S. Bork, A. Diehlmann, et al 2008. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy 10: 676-685.
63. Jones, E., A. English, S. Kinsey, et al 2006. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin. Cytom. 70: 391-399.
64. Poloni, A., G. Maurizi, V. Rosini, et al 2009. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. Cytotherapy 11: 153-162.
65. Quirici, N., D. Soligo, P. Bossolasco, et al 2002. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. 30: 783-791.
66. Liu, L., Z. Sun, B. Chen, et al 2006. Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human. Stem Cells Dev. 15: 349-357.
67. Gentry, T., S. Foster, L. Winstead, et al 2007. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 9: 259-274.
68. Martinez, C., T. Hofmann, R. Marino, et al 2007. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 109: 4245-4248.
69. Gronthos, S., R. McCarty, K. Mrozik, et al 2009. Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells Dev. 18: 1253-1262.
70. Buhring, H.J., V.L. Battula, S. Treml, et al 2007. Novel markers for the prospective isolation of human MSC. Ann. N. Y. Acad.Sci. 1106: 262-271.
71. Masuda, H., S.S. Anwar, H.J. Buhring, et al 2012. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant. [Epub ahead of print] PMID: 22469435.
72. Krinner, A., M. Hoffmann, M. Loeffler, et al 2010. Individual fates of mesenchymal stem cells in vitro. BMC. Syst. Biol. 4: 73.
73. Lin, C.S., Z.C. Xin, C.H. Deng, et al 2010. Defining adipose tissue-derived stem cells in tissue and in culture. Histol. Histopathol. 25: 807-815.
74. Harichandan, A. & H.J. Buhring 2011. Prospective isolation of human MSC. Best. Pract. Res. Clin. Haematol. 24: 25-36.
75. Gronthos, S., A.C. Zannettino, S.E. Graves, et al 1999. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J. Bone Miner. Res. 14: 47-56.
76. Wang, X., H. Hisha, S. Taketani, et al 2005. Neural cell adhesion molecule contributes to hemopoiesis-supporting capacity of stromal cell lines. Stem Cells 23: 1389-1399.
77. Kato, J., H. Hisha, X.L. Wang, et al 2008. Contribution of neural cell adhesion molecule (NCAM) to hemopoietic system in monkeys. Ann. Hematol. 87: 797-807.
78. Wang, X., H. Hisha, T. Mizokami, et al 2010. Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule. Haematologica 95: 884-891.
79. Tormin, A., O. Li, J.C. Brune, et al 2011. CD146 expression on primary non-hematopoietic bone marrow stem cells correlates to in situ localization. Blood. 19: 5067-5077.
80. Parolini, O., F. Alviano, G.P. Bagnara, et al 2008. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
81. Marongiu, F., R. Gramignoli, Q. Sun, et al 2010. Isolation of amniotic mesenchymal stem cells. Curr. Protoc. Stem Cell Biol. 12: 1E.5.1-1E.5.11.
82. Miki, T., F. Marongiu, K. Dorko, et al 2010. Isolation of amniotic epithelial stem cells. Curr. Protoc. Stem Cell Biol. 3: 1E.3.1-1E.3.9.
83. Subrahmanyam, M. 1995. Amniotic membrane as a cover for microskin grafts. Br. J. Plast. Surg. 48: 477-478.
84. Diaz-Prado, S., E. Muinos-Lopez, T. Hermida-Gomez, et al 2011. Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation 81: 162-171.
85. Parolini, O., M. Soncini, M. Evangelista & D. Schmidt 2009. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen. Med. 4: 275-291.
86. Toda, A., M. Okabe, T. Yoshida & T. Nikaido 2007. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J. Pharmacol. Sci. 105: 215-228.
87. Tsuji, H., S. Miyoshi, Y. Ikegami, et al. 2010. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res. 106: 1613-1623.
88. Gomes, J.A., A. Romano, M.S. Santos & H.S. Dua 2005. Amniotic membrane use in ophthalmology. Curr. Opin. Ophthalmol. 16: 233-240.
89. Sakuragawa, N., H. Misawa, K. Ohsugi, et al 1997. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci. Lett. 232: 53-56.
90. Elwan, M.A. & N. Sakuragawa 1997. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 8: 3435-3438.
91. Zhao, P., H. Ise, M. Hongo, et al 2005. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79: 528-535.
92. Strom, S.C., P. Bruzzone, H. Cai, et al 2006. Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant. 15(Suppl. 1): S105-S110.